#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16228	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2233	713.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1486	1486	C	934	C	921	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16228	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2233	713.5	0	HET	.	.	.	C451T,G	.	451	451	C	753	753	C	924	C,T,G	507,393,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16228	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2233	713.5	0	HET	.	.	.	C207T	.	207	207	C	509	509	C	907	C,T	712,169	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3559	838.4	0	.	n	.	0	T695C	SNP	695	695	T	974	974	C	878	C,T	814,45	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3559	838.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2250	2250	C	889	C	872	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3559	838.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2324	2324	A	919	A	907	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3559	838.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2876	2876	C	955	C	933	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3559	838.4	0	HET	.	.	.	A1638G	.	1638	1638	A	1917	1917	A	954	A,G	524,409	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1860	folP	855	855	100.0	folP.l15.c4.ctg.1	1431	127.7	1	SNP	p	R229S	1	.	.	685	687	AGC	953	955	AGC	194;195;195	A;G;C	187;188;189	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	5734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	169.4	1	SNP	p	S91F	1	.	.	271	273	TTC	558	560	TTC	193;192;192	T;T;C	191;190;190	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	5734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	169.4	1	SNP	p	D95G	1	.	.	283	285	GGC	570	572	GGC	190;188;187	G;G;C	188;185;187	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	5734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	169.4	1	SNP	p	G95N	0	.	.	283	285	GGC	570	572	GGC	190;188;187	G;G;C	188;185;187	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1934	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1286	148.2	1	SNP	p	G45D	0	.	.	133	135	GGC	423	425	GGC	245;243;244	G,C;G,A;C	239,1;227,14;240	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	980	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	971	98.5	0	.	n	.	0	A197.	DEL	197	197	A	629	629	A	234	A	230	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	185.7	1	SNP	p	D86N	0	.	.	256	258	GAC	658	660	GAC	211;213;217	G,A;A,C;C	196,9;201,1;213	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	185.7	1	SNP	p	R87I	0	.	.	259	261	CGT	661	663	CGT	214;213;215	C,A;G;T	200,10;209;207	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	185.7	1	SNP	p	R87W	0	.	.	259	261	CGT	661	663	CGT	214;213;215	C,A;G;T	200,10;209;207	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	185.7	1	SNP	p	S87R	1	.	.	259	261	CGT	661	663	CGT	214;213;215	C,A;G;T	200,10;209;207	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5572	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	185.7	1	SNP	p	S88P	0	.	.	262	264	TCC	664	666	TCC	215;213;211	T;C;C	209;204;206	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4220	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2573	161.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1541	1543	GGC	206;204;202	G;G;C	202;201;195	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1238	1240	GCC	225;223;225	G;C;C,A	219;217;218,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1241	1243	ATG	224;223;224	A;T;G,C	220;220;217,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1253	1255	ACC	214;212;217	A,G;C,T;C,G	204,1;208,1;212,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1253	1255	ACC	214;212;217	A,G;C,T;C,G	204,1;208,1;212,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1754	1756	ACC	194;191;190	A,C;C;C	186,1;188;188	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1808	1810	GCG	186;183;185	G;C;G	182;179;179	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1808	1810	GCG	186;183;185	G;C;G	182;179;179	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1931	1933	GGT	167;161;159	G;G;T,C	162;157;143,7	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1940	1942	AGC	147;145;142	A,G;G;C	135,7;144;136	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	163.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1958	1960	CCG	100;102;100	C,G;C;G	92,1;89;84	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	155	97.42	penA.l15.c4.ctg.2	155	0.0	0	.	p	.	0	A160V	NONSYN	478	480	GCA	44	46	GTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	155	97.42	penA.l15.c4.ctg.2	155	0.0	0	.	p	.	0	S173N	NONSYN	517	519	AGC	83	85	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	146	92.47	penA.l15.c4.ctg.5	146	10.7	0	.	p	.	0	V279A	NONSYN	835	837	GTC	83	85	GCC	15;15;15	G;C;C	15;15;14	.	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	146	92.47	penA.l15.c4.ctg.5	146	10.7	0	.	p	.	0	E285D	NONSYN	853	855	GAG	101	103	GAT	15;15;15	G;A;T	14;14;14	.	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	146	92.47	penA.l15.c4.ctg.5	146	10.7	0	.	p	.	0	K288R	NONSYN	862	864	AAA	110	112	AGA	12;12;12	A;G;A	12;12;11	.	.
penA.34.001	penA.34.001	1	1	527	4218	penA	1746	146	92.47	penA.l15.c4.ctg.5	146	10.7	0	.	p	.	0	Q291R	NONSYN	871	873	CAG	119	121	CGG	11;11;11	C;G;G	11;11;11	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6458	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3104	204.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1670	1672	CCG	185;185;188	C;C,T,A;G,C	175;174,6,1;180,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2780	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1731	156.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	562	562	C	180	C,G	173,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	A251V	NONSYN	751	753	GCG	72	74	GTA	24;24;24	G;T,C;A,G	22;21,1;20,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	132	134	ACT	48;47;46	A,T;C;T	46,2;47;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	138	140	GAT	39;37;37	G,C;A;T	34,2;37;36	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	D276N	NONSYN	826	828	GAT	147	149	AAC	37;37;37	A,G;A;C	33,4;37;37	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	150	152	CAC	37;37;37	C,T;A;C	34,2;37;36	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	240	242	GAA	8;8;9	G;A;A	8;8;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	252	254	GCA	9;9;9	G;C;A	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	255	257	GAC	9;10;10	G;A;C	8;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	261	263	ATC	10;10;10	A;T;C	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	267	269	TCG	11;12;12	T;C;G	10;11;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	273	275	GCC	12;12;12	G;C;C	11;12;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	276	278	AGC	12;12;12	A;G;C	11;11;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	279	281	GCC	12;13;13	G;C;C	11;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	390	20.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	285	287	GTT	12;12;12	G;T;T	11;11;10	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3232	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1613	196.2	1	SNP	p	G120K	1	.	.	358	360	AAG	599	601	AAG	242;242;242	A,G;A;G,T,A	231,1;238;223,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3232	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1613	196.2	1	SNP	p	N121D	0	.	.	361	363	AAC	602	604	AAC	244;245;241	A,G;A,C;C	229,12;242,1;233	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3232	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1613	196.2	1	SNP	p	A121N	1	.	.	361	363	AAC	602	604	AAC	244;245;241	A,G;A,C;C	229,12;242,1;233	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	11	11040	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4785	226.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	11	11040	rpoB	4179	115	99.13	rpoB.l15.c4.ctg.2	115	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1300	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	976	130.8	1	SNP	p	V57M	1	.	.	169	171	ATG	516	518	ATG	278;279;271	A,G;T;G,A	273,1;271;264,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
